Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions